Struggling With Great Stock Picks? Discover StockInvest.us Top Gems!
NASDAQ:ECYT
Delisted

Endocyte Fund Price (Quote)

$23.99
+0 (+0%)
At Close: Jan 18, 2019

Range Low Price High Price Comment
30 days $23.97 $24.00 Friday, 18th Jan 2019 ECYT stock ended at $23.99. During the day the stock fluctuated 0% from a day low at $23.99 to a day high of $23.99.
90 days $23.37 $24.00
52 weeks $2.81 $24.00

Historical Endocyte prices

Date Open High Low Close Volume
Apr 04, 2018 $8.31 $8.88 $8.27 $8.81 1 054 338
Apr 03, 2018 $8.24 $8.53 $8.05 $8.42 1 383 142
Apr 02, 2018 $9.00 $9.13 $8.23 $8.25 1 658 583
Mar 29, 2018 $8.80 $9.44 $8.55 $9.09 2 197 860
Mar 28, 2018 $9.01 $9.08 $8.52 $8.80 1 540 206
Mar 27, 2018 $9.94 $10.06 $8.93 $8.97 2 137 057
Mar 26, 2018 $10.37 $10.82 $9.81 $9.94 1 929 922
Mar 23, 2018 $10.29 $10.78 $10.18 $10.29 1 824 199
Mar 22, 2018 $10.61 $11.28 $10.23 $10.31 2 892 924
Mar 21, 2018 $9.89 $11.23 $9.84 $10.68 3 122 301
Mar 20, 2018 $9.89 $10.14 $9.58 $9.85 1 417 174
Mar 19, 2018 $9.63 $10.01 $9.34 $9.92 1 693 085
Mar 16, 2018 $10.31 $10.44 $9.28 $9.83 3 218 564
Mar 15, 2018 $10.15 $11.38 $9.82 $10.34 3 315 997
Mar 14, 2018 $10.42 $10.75 $9.31 $10.38 5 905 290
Mar 13, 2018 $9.00 $11.54 $8.56 $10.82 12 250 938
Mar 12, 2018 $8.00 $9.32 $7.70 $8.83 7 628 461
Mar 09, 2018 $9.07 $9.16 $7.46 $8.20 12 122 653
Mar 08, 2018 $7.25 $8.97 $7.25 $8.06 8 195 059
Mar 07, 2018 $6.95 $7.36 $6.77 $7.31 3 071 550
Mar 06, 2018 $6.29 $7.36 $6.28 $7.04 5 316 078
Mar 05, 2018 $6.39 $6.79 $6.20 $6.33 4 013 341
Mar 02, 2018 $5.73 $6.70 $5.71 $6.50 6 227 851
Mar 01, 2018 $5.75 $6.00 $5.52 $5.90 4 804 531
Feb 28, 2018 $4.56 $6.08 $4.51 $5.93 22 715 946
Click to get the best stock tips daily for free!

About Endocyte

Endocyte, Inc., a biopharmaceutical company, develops targeted therapies for the treatment of cancer and inflammatory diseases in the United States. The company uses its technology to create novel small molecule drug conjugates (SMDCs) and companion imaging agents. It is developing Vintafolide, a SMDC that is in Phase IIb clinical trials to treat non-small cell lung cancer; EC1456, which is in Phase I dose escalation trial for the treatment of ad... ECYT Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT